Published:
Apogee's Common Stock Begins Quotation on the Over-the-Counter Bulletin Board
Apogee Technology, Inc. (OTCBB: ATCS) (the
"Company") announced today that effective immediately, its shares will also
be quoted on the Over-the-Counter Bulletin Board® under the symbol
"ATCS." Some users of quotation publication services will be required to
enter "ATCS.OB."
About Apogee Technology, Inc.
Apogee Technology, Inc. is a biotechnology company developing proprietary
systems for the delivery of pharmaceutical agents into the skin for the
treatment and prevention of local and systemic conditions. The Company's
PyraDerm(TM) delivery system incorporates structured solid-state
formulations designed to penetrate the outer layer of the skin and then
release the agent in a controlled manner. The Company is also developing
and commercializing sensors and sensor systems with a specialized focus on
health monitoring systems. For more information please visit our web site
at: http://www.apogeebio.com.
PyraDerm(TM), Sensilica® and IntellaPAL(TM) are trademarks of Apogee
Technology, Inc. All other product names noted herein may be trademarks of
their respective holders.
Certain statements made herein that use the words "anticipate," "may,"
"hope," "estimate," "project," "will," "intend," "plan," "expect,"
"believe" and similar expressions are intended to identify forward-looking
statements within the meaning of the Private Securities Litigation Reform
Act of 1995. These forward-looking statements involve those oriented to
the Company's continued trading status, capital raising transactions and
its interaction with future quotation or listing services in addition to
those related to the design, development and production efforts of our
PyraDerm(TM), Sensilica® and IntellaPAL(TM) technologies, known and
unknown risks and uncertainties, which could cause the actual results,
performance or achievements of the Company to be materially different from
those that may be expressed or implied. Please refer to the company's risk
factors as set forth in the Company's filings with the Securities and
Exchange Commission, including its report on Form 10-KSB, as amended, for
the year ended December 31, 2006 and its quarterly reports on Form 10-QSB,
for the quarters ended March 31, 2007, June 30, 2007 and September 30,
2007.
Copyright © 2009, MarketWire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,Pharmaceuticals and Biotech:Biotech, PharmaceuticalsandBiotech:Trials, PharmaceuticalsandBiotech:EquipmentandSupplies, PharmaceuticalsandBiotech:Drugs, ,OTCBULLB,OTCBULLB,OTCBULLB,MA,NORWOOD, MA
Search News
Daily News
